Min Li,Chengliang Zhang,Xiaofang Shangguan,Rui Huang,Dong Liu,Chengliang Zhang. Intervention for oxaliplatin-induced hypersensitivity in China: a cross-sectional internet-based survey. Oncol Transl Med, 2020, 6: 277-281.
Intervention for oxaliplatin-induced hypersensitivity in China: a cross-sectional internet-based survey
Received:June 28, 2020  Revised:December 04, 2020
View Full Text  View/Add Comment  Download reader
KeyWord:oxaliplatin; hypersensitivity reactions; intervention; cross-sectional survey
Author NameAffiliationE-mail
Min Li Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2254765273@qq.com 
Chengliang Zhang Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  
Yue Wang Statistical Department, Tongji Hospital Affiliated with Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  
Xiaofang Shangguan School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  
Rui Huang School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  
Dong Liu Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  
Chengliang Zhang Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China clzhang@tjh.tjmu.edu.cn 
Hits: 781
Download times: 1456
Abstract:
      Objective This cross-sectional study aimed at investigating the intervention status and the influence of oncologists on oxaliplatin-induced hypersensitivity reactions (OIHR). Methods Snowball sampling was used to send questionnaires to oncologists in various provinces and cities in China, via the internet, to collect data on their socio-demographic characteristics, the occurrence of OIHR, and the current status of interventions. One-way ANOVA and T-test of geographic samples were used to explore the relationship between the incidence of OIHR and intervention measures. Results A total of 401 valid questionnaires were collected, most respondents were 30–40 years old, and most oncologists had 5 years of working experience. The proportions of glucocorticoid and H1 receptor antagonist use for OIHR prevention were 67.83% and 38.65%, respectively. The proportion of oncologists with longer working years and higher professional titles who used glucocorticoids for OIHR prevention was higher, and the observed OIHR incidence was lower. Pretreatment with glucocorticoids may be an effective preventive measure and can reduce the incidence of the OXA allergic reactions (P < 0.05). Conclusion The risk awareness of junior oncologists to OIHR prevention should be strengthened, and clinical efficacy evaluation of glucocorticoids in OIHR prevention should be further promoted.
Close